Filter Results

Clinical Studies

Open

  • Preoperative Radiosurgery In High Grade Glioma: A Phase I/IIA Clinical Trial: The NeoGlioma Study Scottsdale/Phoenix, AZ

    This study aims to evaluate the safety of preoperative radiosurgery in the treatment of patients with biopsy-proven high grade glioma prior to conventional therapy. Safety is defined as any acute grade 3 (CTCAE v5.0) or greater unplanned adverse event from the time of enrollment until 4 weeks following postoperative radiotherapy.

  • Stereotactic Advanced-imaging Guided Radiotherapy For GlioblastomA (SAGA 2.0) Albert Lea, MN Eau Claire, WI La Crosse, WI Mankato, MN Rochester, MN

    Cohort 1 is a phase III design randomized trial of patients with newly diagnosed glioblastoma with a primary endpoint to determine whether overall survival is significantly improved with dose-intensified radiation over accelerated radiation.

    Cohort 2 includes patients with glioblastoma who are not eligible for six weeks of radiation and therefore not eligible for Cohort 1. Cohort 2 is a Bayesian design trial to determine if intensified accelerated radiation improves survival compared to accelerated radiation. 

Contact Us for the Latest Status

Closed for Enrollment

.